Akso Health Group (AHG)
NASDAQ: AHG · Real-Time Price · USD
0.8480
-0.0258 (-2.95%)
At close: Sep 4, 2026, 4:00 PM EDT
0.9120
+0.0640 (7.55%)
After-hours: Sep 4, 2026, 7:30 PM EDT
Akso Health Group Balance Sheet
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Assets
Fiscal Quarter | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 |
Cash & Equivalents | 0.17 | 0.17 | 11.13 | 11.13 | 176.23 | 176.23 | 91.37 | 91.37 | 85.17 | 85.17 |
Cash & Short-Term Investments | 0.17 | 0.17 | 11.13 | 11.13 | 176.23 | 176.23 | 91.37 | 91.37 | 85.17 | 85.17 |
Cash Growth (YoY) | -99.90% | -99.90% | -87.82% | -87.82% | 106.91% | 106.91% | 886.32% | 886.32% | - | - |
Accounts Receivable | 1.28 | 1.28 | 3.17 | 3.17 | 0.95 | 0.95 | 0.41 | 0.41 | - | - |
Receivables | 1.28 | 1.28 | 5.87 | 5.87 | 12.9 | 12.9 | 0.41 | 0.41 | - | - |
Inventory | 0.2 | 0.2 | 0.19 | 0.19 | 0.19 | 0.19 | 0.2 | 0.2 | 0.19 | 0.19 |
Other Current Assets | 187.89 | 187.89 | 1.2 | 1.2 | 6.81 | 6.81 | 8.24 | 8.24 | 56.65 | 56.65 |
Total Current Assets | 189.55 | 189.55 | 18.39 | 18.39 | 196.12 | 196.12 | 100.21 | 100.21 | 142.02 | 142.02 |
Property, Plant & Equipment | 0.03 | 0.03 | 0.09 | 0.09 | 0.11 | 0.11 | 0.24 | 0.24 | - | - |
Goodwill | - | - | 11.04 | 11.04 | 10.83 | 10.83 | 112.5 | 112.5 | - | - |
Other Intangible Assets | 0.06 | 0.06 | 6.85 | 6.85 | 7.88 | 7.88 | - | - | - | - |
Other Long-Term Assets | - | - | 175.66 | 175.66 | - | - | - | - | - | - |
Total Assets | 189.63 | 189.63 | 212.04 | 212.04 | 214.95 | 214.95 | 212.95 | 212.95 | 142.02 | 142.02 |
Liabilities
Fiscal Quarter | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 |
Accounts Payable | - | - | - | - | - | - | 0.26 | 0.26 | - | - |
Accrued Expenses | 1.84 | 1.84 | 1.74 | 1.74 | 1.46 | 1.46 | 1.29 | 1.29 | 1.09 | 1.09 |
Short-Term Debt | 2.35 | 2.35 | 2 | 2 | 2 | 2 | 6.65 | 6.65 | 2 | 2 |
Current Portion of Leases | 0.02 | 0.02 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | - | - |
Current Income Taxes Payable | 0.09 | 0.09 | 0.24 | 0.24 | 0.09 | 0.09 | 0.13 | 0.13 | 0.09 | 0.09 |
Other Current Liabilities | 4.41 | 4.41 | 7.99 | 7.99 | 10.22 | 10.22 | 3.86 | 3.86 | 0.42 | 0.42 |
Total Current Liabilities | 8.71 | 8.71 | 12.02 | 12.02 | 13.81 | 13.81 | 12.23 | 12.23 | 3.59 | 3.59 |
Long-Term Leases | 0 | 0 | 0.02 | 0.02 | 0.04 | 0.04 | 0.06 | 0.06 | - | - |
Long-Term Deferred Tax Liabilities | - | - | 1.69 | 1.69 | 1.95 | 1.95 | - | - | - | - |
Total Liabilities | 8.71 | 8.71 | 13.73 | 13.73 | 15.8 | 15.8 | 12.3 | 12.3 | 3.59 | 3.59 |
Shareholders' Equity
Fiscal Quarter | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 |
Common Stock | 0.26 | 0.26 | 0.26 | 0.26 | 0.17 | 0.17 | 0.07 | 0.07 | 0.04 | 0.04 |
Additional Paid-In Capital | 405.53 | 405.53 | 405.53 | 405.53 | 405.62 | 405.62 | 273.05 | 273.05 | 210.32 | 210.32 |
Retained Earnings | -217.58 | -217.58 | -200.18 | -200.18 | -198.9 | -198.9 | -64.51 | -64.51 | -63.93 | -63.93 |
Treasury Stock | -3.99 | -3.99 | -3.99 | -3.99 | -3.99 | -3.99 | -3.99 | -3.99 | -3.99 | -3.99 |
Comprehensive Income & Other | -3.28 | -3.28 | -3.31 | -3.31 | -3.77 | -3.77 | -4.06 | -4.06 | -4.09 | -4.09 |
Total Common Equity | 180.93 | 180.93 | 198.3 | 198.3 | 199.12 | 199.12 | 200.56 | 200.56 | 138.37 | 138.37 |
Minority Interest | -0.01 | -0.01 | 0.01 | 0.01 | 0.03 | 0.03 | 0.09 | 0.09 | 0.06 | 0.06 |
Shareholders' Equity | 180.92 | 180.92 | 198.31 | 198.31 | 199.15 | 199.15 | 200.65 | 200.65 | 138.42 | 138.42 |
Total Liabilities & Equity | 189.63 | 189.63 | 212.04 | 212.04 | 214.95 | 214.95 | 212.95 | 212.95 | 142.02 | 142.02 |
Additional Metrics
Fiscal Quarter | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 |
Total Debt | 2.38 | 2.38 | 2.06 | 2.06 | 2.08 | 2.08 | 6.75 | 6.75 | 2 | 2 |
Net Cash (Debt) | -2.21 | -2.21 | 9.07 | 9.07 | 174.15 | 174.15 | 84.62 | 84.62 | 83.17 | 83.17 |
Net Cash Growth (YoY) | - | - | -89.29% | -89.29% | 109.38% | 109.38% | - | - | - | - |
Net Cash Per Share | -0.00 | -0.00 | 0.02 | 0.01 | 0.61 | 0.32 | 0.56 | 0.35 | 1.76 | 2.38 |
Filing Date Shares Outstanding | 856.7 | 856.7 | 856.7 | 856.7 | 551.86 | 551.86 | 239.9 | 239.9 | 145.72 | 145.72 |
Total Common Shares Outstanding | 856.7 | 856.7 | 856.7 | 856.7 | 551.86 | 551.86 | 239.9 | 239.9 | 145.72 | 145.72 |
Working Capital | 180.84 | 180.84 | 6.37 | 6.37 | 182.31 | 182.31 | 87.98 | 87.98 | 138.42 | 138.42 |
Book Value Per Share | 0.21 | 0.21 | 0.23 | 0.23 | 0.36 | 0.36 | 0.84 | 0.84 | 0.95 | 0.95 |
Tangible Book Value | 180.88 | 180.88 | 180.41 | 180.41 | 180.41 | 180.41 | 88.06 | 88.06 | 138.37 | 138.37 |
Tangible Book Value Per Share | 0.21 | 0.21 | 0.21 | 0.21 | 0.33 | 0.33 | 0.37 | 0.37 | 0.95 | 0.95 |
Machinery | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | - | - | - | - |